1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Preterm Birth And PROM Testing Market
2.2. Global Preterm Birth And PROM Testing Market, By Test, 2023 (US$ Million)
2.3. Global Preterm Birth And PROM Testing Market, By Geography, 2023 (US$ Million)
2.4. Attractive Investment Proposition by Geography, 2023
3. Preterm Birth And PROM Testing Market: Competitive Analysis
3.1. Market Positioning of Key Preterm Birth And PROM Testing Market Vendors
3.2. Strategies Adopted by Preterm Birth And PROM Testing Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2023 Versus 2032
4. Preterm Birth And PROM Testing Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Preterm Birth And PROM Testing Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape
5. Preterm Birth And PROM Testing Market: By Test, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Pelvic Exam
5.3.2. Ferning Test
5.3.3. Nitrazine Test
5.3.4. Pooling Test
5.3.5. Ultrasound Test
5.3.6. Uterine Monitoring Test
5.3.7. Biomarkers
6. North America Preterm Birth And PROM Testing Market, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Preterm Birth And PROM Testing Market: By Test, 2022-2032, USD (Million)
6.3.Preterm Birth And PROM Testing Market: By Region, 2022-2032, USD (Million)
6.3.1.North America
6.3.1.1. U.S.
6.3.1.1.1. Preterm Birth And PROM Testing Market: By Test, 2022-2032, USD (Million)
6.3.1.2. Canada
6.3.1.2.1. Preterm Birth And PROM Testing Market: By Test, 2022-2032, USD (Million)
6.3.1.3. Rest of North America
6.3.1.3.1. Preterm Birth And PROM Testing Market: By Test, 2022-2032, USD (Million)
7. UK and European Union Preterm Birth And PROM Testing Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Preterm Birth And PROM Testing Market: By Test, 2022-2032, USD (Million)
7.3.Preterm Birth And PROM Testing Market: By Region, 2022-2032, USD (Million)
7.3.1.UK and European Union
7.3.1.1. UK
7.3.1.1.1. Preterm Birth And PROM Testing Market: By Test, 2022-2032, USD (Million)
7.3.1.2. Germany
7.3.1.2.1. Preterm Birth And PROM Testing Market: By Test, 2022-2032, USD (Million)
7.3.1.3. Spain
7.3.1.3.1. Preterm Birth And PROM Testing Market: By Test, 2022-2032, USD (Million)
7.3.1.4. Italy
7.3.1.4.1. Preterm Birth And PROM Testing Market: By Test, 2022-2032, USD (Million)
7.3.1.5. France
7.3.1.5.1. Preterm Birth And PROM Testing Market: By Test, 2022-2032, USD (Million)
7.3.1.6. Rest of Europe
7.3.1.6.1. Preterm Birth And PROM Testing Market: By Test, 2022-2032, USD (Million)
8. Asia Pacific Preterm Birth And PROM Testing Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Preterm Birth And PROM Testing Market: By Test, 2022-2032, USD (Million)
8.3.Preterm Birth And PROM Testing Market: By Region, 2022-2032, USD (Million)
8.3.1.Asia Pacific
8.3.1.1. China
8.3.1.1.1. Preterm Birth And PROM Testing Market: By Test, 2022-2032, USD (Million)
8.3.1.2. Japan
8.3.1.2.1. Preterm Birth And PROM Testing Market: By Test, 2022-2032, USD (Million)
8.3.1.3. India
8.3.1.3.1. Preterm Birth And PROM Testing Market: By Test, 2022-2032, USD (Million)
8.3.1.4. Australia
8.3.1.4.1. Preterm Birth And PROM Testing Market: By Test, 2022-2032, USD (Million)
8.3.1.5. South Korea
8.3.1.5.1. Preterm Birth And PROM Testing Market: By Test, 2022-2032, USD (Million)
8.3.1.6. Rest of Asia Pacific
8.3.1.6.1. Preterm Birth And PROM Testing Market: By Test, 2022-2032, USD (Million)
9. Latin America Preterm Birth And PROM Testing Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Preterm Birth And PROM Testing Market: By Test, 2022-2032, USD (Million)
9.3.Preterm Birth And PROM Testing Market: By Region, 2022-2032, USD (Million)
9.3.1.Latin America
9.3.1.1. Brazil
9.3.1.1.1. Preterm Birth And PROM Testing Market: By Test, 2022-2032, USD (Million)
9.3.1.2. Mexico
9.3.1.2.1. Preterm Birth And PROM Testing Market: By Test, 2022-2032, USD (Million)
9.3.1.3. Rest of Latin America
9.3.1.3.1. Preterm Birth And PROM Testing Market: By Test, 2022-2032, USD (Million)
10. Middle East and Africa Preterm Birth And PROM Testing Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Preterm Birth And PROM Testing Market: By Test, 2022-2032, USD (Million)
10.3.Preterm Birth And PROM Testing Market: By Region, 2022-2032, USD (Million)
10.3.1.Middle East and Africa
10.3.1.1. GCC
10.3.1.1.1. Preterm Birth And PROM Testing Market: By Test, 2022-2032, USD (Million)
10.3.1.2. Africa
10.3.1.2.1. Preterm Birth And PROM Testing Market: By Test, 2022-2032, USD (Million)
10.3.1.3. Rest of Middle East and Africa
10.3.1.3.1. Preterm Birth And PROM Testing Market: By Test, 2022-2032, USD (Million)
11. Company Profile
11.1. Abbott Laboratories, Inc.
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Portfolio
11.1.4. Strategic Initiatives
11.2. Biosynex
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Portfolio
11.2.4. Strategic Initiatives
11.3. Clinical Innovations, LLC
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Portfolio
11.3.4. Strategic Initiatives
11.4. CooperSurgical, Inc.
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Portfolio
11.4.4. Strategic Initiatives
11.5. Hologic, Inc.
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Portfolio
11.5.4. Strategic Initiatives
11.6. IQ Products.
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Portfolio
11.6.4. Strategic Initiatives
11.7. Medixbiochemica
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Portfolio
11.7.4. Strategic Initiatives
11.8. NX Prenatal, Inc.
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Portfolio
11.8.4. Strategic Initiatives
11.9. Qiagen N.V.
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Portfolio
11.9.4. Strategic Initiatives
11.10. Sera Prognostics, Inc.
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Product Portfolio
11.10.4. Strategic Initiatives